Home/Filings/4/0001209191-13-057424
4//SEC Filing

SPECTRUM PHARMACEUTICALS INC 4

Accession 0001209191-13-057424

CIK 0000831547operating

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:59 PM ET

Size

7.3 KB

Accession

0001209191-13-057424

Insider Transaction Report

Form 4
Period: 2013-12-13
LENAZ LUIGI MD
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2013-12-13+20,00020,000 total
    Exercise: $9.18From: 2013-12-13Exp: 2023-12-13Common Stock (20,000 underlying)
  • Award

    Common Stock, $0.001 par value

    2013-12-13+10,00039,077 total
Footnotes (2)
  • [F1]50% of the restricted shares will vest on June 13, 2014. The remaining 50% of restricted shares will vest on December 13, 2014.
  • [F2]25% of the option shares shall vest on December 13, 2013. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.

Issuer

SPECTRUM PHARMACEUTICALS INC

CIK 0000831547

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000831547

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:59 PM ET
Size
7.3 KB